TY - JOUR 
A1 - López Galindo, Mónica Paula
AU - Bagán Sebastián, José Vicente
T1 - Apixaban and oral implications
Y1 - 2015
SN - 19895488
UR - http://hdl.handle.net/11268/4582
AB - Thrombotic disorders remain a leading cause of death in the Western world, and in this regard a
number of anticoagulation treatment have been used, including heparins, fondaparinux, vitamin K antagonists
(warfarin, acenocoumarol), and new oral anticoagulants such as apixaban.
For years there has been great controversy regarding the use of anticoagulants in planning dental treatments that
imply bleeding. The main concerns about using new oral anticoagulants in invasive dental procedures are bleeding
due to the lack of an antidote, and the thrombotic risk of the disease for which anticoagulation was indicated in the
first place.
KW - Apixaban
KW - Dental treatment
KW - Dental implications
KW - Medicamentos
KW - Odontología
KW - Medicamento
KW - Odontología
LA - eng
ER -